SYMPOSIUM
21 - 22 may 2024 · Parc Científic de Barcelona
The Barcelona
Blood-Brain-Barrier (B4)
symposium
Building Networks, Overcoming Barriers
To fulfil the promise of applying bioengineering to improve the lives of patients, we need to adopt a holistic approach encompassing understanding of biological/pathological mechanisms, development of engineered systems, and consideration of clinical needs. Hence, the B4 symposium, by bringing together experts studying the BBB from a biological, engineering and medical perspective, will greatly aid IBEC in its goal of developing bioengineering solutions to deliver therapies against brain disorders.
Barcelona is home to numerous research groups pushing forward the knowledge frontier of the blood-brain barrier (BBB) and its role in brain disorders. To foment interaction across this community, we are organizing the Barcelona Blood-Brain-Barrier (B4) symposium to bring the BBB-community of Barcelona together to discuss advances in the field. The event will focus on the mechanisms underlying BBB physiology (e.g., brain endothelial specialization, neurovascular coupling, molecular transport), its role in brain disorders (neurodegeneration, infectious diseases, cancer), and nano/bioengineering strategies to deliver therapies across the BBB.
The first edition of this symposium will take place on May 21st-22nd, 2024. As our inaugural keynote speaker, we have the honour to welcome Prof. Martin Lauritzen (Copenhagen University). Prof. Lauritzen has been instrumental in our understanding of regulation of cerebral blood-flow by the neurovascular unit, nanoparticle transport dynamics across the BBB, and in developing in vivo imaging systems to study the brain vasculature.
IMPORTANT DEADLINES:
Abstract submission: 15/04/2024 30/04/2024
Notification of acceptance: Beginning May
Registration: 14/05/2024
FEE:
100€
keynote speakers:
Martin Lauritzen, University of Copenhagen
Roberto Villasenor Solorio, Roche- Pharma Research and Early Development (pRED)
SPEAKERS:
Giuseppe Battaglia, Institute for Bioengineering of Catalonia (IBEC)
Maria Bernabeu Aznar, European Molecular Biology Laboratory (EMBL), Barcelona
Giancarlo Franzese, Department of Condensed Matter Phycics, University of Barcelona
Angeles Garcia Cazorla, Hospital Sant Joan de Deu
Ana Lagunas Targarona, Institute for Bioengineering of Catalonia (IBEC)
Kostas Kostarelos, Catalan Institute of Nanoscience and Nanotechnology (ICN2)
Benjamin Oller Salvia, Institute de Quimica de Sarria (IQS), Universitat Ramon Llull
Anna Planas, Instituto de Investigaciones Biomedicas de Barcelona (IibB), CSIC
Anna Rosell Novel, Vall d’Hebron Research Institute
Josep Samitier, Institute for Bioengineering of Catalonia (IBEC)
Simo Schwartz, Vall d’Hebron Hospital
Tom Kisby, Centre for Nanotechnology in Medicine, Manchester University, U.K.
PROGRAMME:
09:30 | Opening Prof. Josep Samitier, Institute for Bioengineering of Catalonia (IBEC) |
10:00 | Two-photon microscopy at the blood-brain barrier Prof. Martin Lauritzen, University of Copenhagen |
11:00 | Prof. Giuseppe Battaglia, Institute for Bioengineering of Catalonia (IBEC) |
11:30 | Coffee break |
11:45 | Combining Experiments, Machine Learning, Simulations and Theory for Engineered Nanoparticles in Drug Delivery. Prof. Giancarlo Franzese, University of Barcelona |
12:15 | Nanoparticulate systems for blood-brain barrier crossing and glioblastoma treatment Dra. Fernanda Andrade, Vall d’Hebron Research Institute |
12:45 | Oral contribution |
13:00 | Lunch break |
14:15 | Engineering BBB models for malaria pathogenesis research Dr. Maria Bernabeu, European Molecular Biology Laboratory (EMBL) |
14:45 | Stages of blood-brain barrier damage after stroke Dr. Anna Planas, Instituto de Investigaciones Biomedicas de Barceloa (LibB), CSIC |
15:15 | Oral Contribution |
15:45 | Coffee break |
16:15 | Flash (oral) presentation |
17:15 | Poster session |
09:30 | Registration |
10:00 | In vitro models to investigate transcytosis across the blood-brain barrier Dr. Roberto Villaseñor, Roche- Pharma Research and Early Development (pRED) |
11:00 | Understanding the principles of nanoparticle translocation kinetics through the injured blood-brain barrier and their therapy implications Dr. Tom Kisby, Centre for Nanotechnology in Medicine, Manchester University, U.K. |
11:30 | Coffee break |
11:45 | The brain glucose transporter defect (Glut1) as a paradigm of neurometabolic disease of the BBB Dr. Angeles Garcia Cazorla, Hospital Sant Joan de Deu |
12:15 | Targeting the blood brain barrier for neurovascular repair Dr. Anna Rosell Novel, Vall d’Hebron Research Institute |
12:45 | Oral contribution |
13:00 | Lunch break |
14:15 | Blood-brain barrier-on-a-chip for drug screening in neurodegenerative diseases Dr. Ana Lagunas, Institute for Bioengineering of Catalonia (IBEC) |
14:45 | Development of shuttle peptides for the transport of biotherapeutics across the blood-brain barrier Dr. Benjamin Oller, Institute de Quimica de Sarria (IQS), Universitat Ramon Llull |
15:15 | Invited talk |
15:45 | Coffee break |
16:15 | Flash (oral) presentation |
17:15 | Poster session |
Organized by:
Venue:
Auditori Antoni Caparrós
Parc Científic de Barcelona
C. Bardiri Reixac, 4-8, Barcelona
CONFERENCE CANCELLATION POLICY
Registrations cancelled before 20th April 2024 are eligible for a refund of the registration fees paid, except from 20€ related to administration costs incurred.
Registrations cancelled after 20th April 2024 are no longer eligible for a refund.